144 related articles for article (PubMed ID: 28544300)
1. Bladder cancer diagnosis during haematuria investigation - implications for practice guidelines.
Ngo B; Papa N; Perera M; Bolton D; Sengupta S
BJU Int; 2017 May; 119 Suppl 5():53-54. PubMed ID: 28544300
[No Abstract] [Full Text] [Related]
2. Breast cancer: Updated screening guidelines - much ado about small improvements.
Jørgensen KJ; Gøtzsche PC
Nat Rev Clin Oncol; 2016 Mar; 13(3):139-40. PubMed ID: 26718110
[No Abstract] [Full Text] [Related]
3. The toll of not screening for colorectal cancer.
Chen C; Hoffmeister M; Brenner H
Expert Rev Gastroenterol Hepatol; 2017 Jan; 11(1):1-3. PubMed ID: 27897033
[No Abstract] [Full Text] [Related]
4. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
[TBL] [Abstract][Full Text] [Related]
5. Hematuria: a problem-based imaging algorithm illustrating the recent Dutch guidelines on hematuria.
van der Molen AJ; Hovius MC
AJR Am J Roentgenol; 2012 Jun; 198(6):1256-65. PubMed ID: 22623537
[TBL] [Abstract][Full Text] [Related]
6. Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.
Ngo B; Papa N; Perera M; Bolton D; Sengupta S
BJU Int; 2017 May; 119 Suppl 5():19-25. PubMed ID: 28544302
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of hematuria home screening for bladder cancer in men.
Cai T; Bartoletti R
Cancer; 2007 May; 109(9):1923-4; author reply 1924. PubMed ID: 17357998
[No Abstract] [Full Text] [Related]
8. The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
Pesch B; Nasterlack M; Eberle F; Bonberg N; Taeger D; Leng G; Feil G; Johnen G; Ickstadt K; Kluckert M; Wellhäusser H; Stenzl A; Brüning T;
BJU Int; 2011 Aug; 108(4):546-52. PubMed ID: 21223477
[TBL] [Abstract][Full Text] [Related]
9. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation.
Cohn JA; Vekhter B; Lyttle C; Steinberg GD; Large MC
Cancer; 2014 Feb; 120(4):555-61. PubMed ID: 24496869
[TBL] [Abstract][Full Text] [Related]
10. Alignment of breast cancer screening guidelines, accountability metrics, and practice patterns.
Onega T; Haas JS; Bitton A; Brackett C; Weiss J; Goodrich M; Harris K; Pyle S; Tosteson AN
Am J Manag Care; 2017 Jan; 23(1):35-40. PubMed ID: 28141929
[TBL] [Abstract][Full Text] [Related]
11. Non-visible versus visible haematuria and bladder cancer risk: a study of electronic records in primary care.
Price SJ; Shephard EA; Stapley SA; Barraclough K; Hamilton WT
Br J Gen Pract; 2014 Sep; 64(626):e584-9. PubMed ID: 25179073
[TBL] [Abstract][Full Text] [Related]
12. Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.
Cha EK; Tirsar LA; Schwentner C; Hennenlotter J; Christos PJ; Stenzl A; Mian C; Martini T; Pycha A; Shariat SF; Schmitz-Dräger BJ
World J Urol; 2012 Dec; 30(6):847-52. PubMed ID: 23124847
[TBL] [Abstract][Full Text] [Related]
13. Editorial comment.
de Reijke TM
Urology; 2010 Jan; 75(1):25; author reply 25-6. PubMed ID: 20109702
[No Abstract] [Full Text] [Related]
14. Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention study.
Liedberg F; Gerdtham U; Gralén K; Gudjonsson S; Jahnson S; Johansson I; Hagberg O; Larsson S; Lind AK; Löfgren A; Wanegård J; Åberg H; Nilbert M
Br J Cancer; 2016 Sep; 115(7):770-5. PubMed ID: 27560554
[TBL] [Abstract][Full Text] [Related]
15. Disparity in bladder cancer outcomes: what's sex got to do with it?
Ristau BT; Davies BJ
Cancer; 2014 Feb; 120(4):461-3. PubMed ID: 24496864
[No Abstract] [Full Text] [Related]
16. Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.
Ngo B; Perera M; Papa N; Bolton D; Sengupta S
BJU Int; 2017 May; 119 Suppl 5():10-18. PubMed ID: 28544294
[TBL] [Abstract][Full Text] [Related]
17. A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma.
Kavalieris L; O'Sullivan PJ; Suttie JM; Pownall BK; Gilling PJ; Chemasle C; Darling DG
BMC Urol; 2015 Mar; 15():23. PubMed ID: 25888331
[TBL] [Abstract][Full Text] [Related]
18. Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy.
Hedelin H; Jonsson K; Salomonsson K; Boman H
Scand J Urol Nephrol; 2006; 40(1):26-30. PubMed ID: 16452052
[TBL] [Abstract][Full Text] [Related]
19. The association between symptoms and bladder or renal tract cancer in primary care: a systematic review.
Schmidt-Hansen M; Berendse S; Hamilton W
Br J Gen Pract; 2015 Nov; 65(640):e769-75. PubMed ID: 26500325
[TBL] [Abstract][Full Text] [Related]
20. 2013 ASCO/CAP updated guidelines for human epidermal growth factor receptor 2 testing: Impact on routine practice.
Pennacchia I; Carbone A; Di Cerbo A; Vecchio FM; Arena V
Breast; 2015 Jun; 24(3):285-6. PubMed ID: 25704981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
